(PREPRINT) Exposure therapy under psilocybin for general anxiety disorder and claustrophobia (Thorens et al.)

Available Online: May 12, 2023
Research Square

~

The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. “Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies” (Jones and Machado-Vieira)

Published: May 12, 2023
Molecular Psychiatry

~

Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care (Nigam et al.)

Published: May 12, 2023
Clinics in Geriatric Medicine